2605 samples of female cervical exfoliated cells were collected from January 2019 to December 2020 in the gynecological outpatient department of the Affiliated Hospital of North China University of Science and Technology. The ages of the patients are at 20 - 68 years (mean 45.0 ± 5.0), and they are all from Tangshan, Hebei Province. They are no history of cervical vertebra resection or hysterectomy, and no HPV testing has been done before, no vaccination against HPV, no drugs were used within 3 days, and no menstruating. These patients included: normal physical examination women and patients with cervical lesions. The collected specimens were divided into two parts and placed in two sterile preservation tubes for marking. The first specimen was made for pathological diagnosis by pathologists. The second sample was used to detect HPV infection types.

Main instruments and reagents: SLAN-96P Real-Time PCR System made by Shanghai Hongshi Medical Technology Company; Real-time fluorescence quantitative PCR kit developed by Shengxiang Biotechnology Company.

The cell smears were prepared by centrifugal precipitation liquid-based thin laminate technique that is as follows: The exfoliated cervical cells were removed using cervical cell brush and gently shake the cells on the brush head into the cell liquid in the numbered bottle containing the preservation solution; 2 ml cell liquid was taken into a centrifuge tube (which had been placed into slides), and then centrifuged at 1500 RPM for 3 min, and then the cell smears were prepared, the centrifuge tube was conducted out and the supernatant was discard, the slides were removed and dry, pap staining was performed.

The staining results were interpreted as follows: the nuclei were dyed dark blue and the nucleoli were dyed red. The cytoplasmic color of squamous epithelial cells was also significantly different with different degrees of differentiation and maturation: the dark pink cells were keratinocytes, the orange cells were incomplete keratinocytes, and the pre-keratinocytes were light emerald green or light azure blue. The pathological cytological analysis and diagnosis were made according to the grading system of the American TBS (the 2014 Bethesda system) through an optical microscope.

• Specimen treatment: 1 ml specimen was put into 1.5 ml EP tube, remove the supernatant after instantaneous centrifugation, and take 50 μl samples into another sterile EP tube, add 50 μl nucleic acid lysate, and mix it upside down, which is used as the templates of the samples (including negative and positive control 50 μl each).

• Specimen Quality detection β-Actin was used as an internal reference to detect the quality of the specimen. The β-actin Primers are as follows: Forward TCACCCACACTGTGCCCATCT, Reverse GAACCGCTCATTGCCAATGG, the PCR product size 290 bp. The 293-cell DNA containing the home-guarding gene was used as a positive control to detect whether these samples could meet the requirements of further experiments.

• PCR amplification detected HPV types: HPV types were detected using PCR amplification through the real-time PCR kit for quantitative fluorescence analysis developed by Shengxiang Biotechnology Group, which could simultaneously test 15 high-risk HPV types including HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68. All PCR components were added into 200 ml sterile EP tube according to kit instructions, and 10 ml above sample templates (including control group) was added; PCR reaction cycle parameters: Reaction with UNG enzyme at 50˚C for about 2 min; Taq enzyme was activated at 94˚C for 5 min. 40 cycles: 94˚C denaturation 15 sec, 57˚C annealing, extension and fluorescence acquisition 30 sec; Run at 25˚C for 10 sec.

Statistical analysis was conducted using the SPSS17.0 software system based on the Excel database. Counting data between groups was used X2 test. There is a significant difference based on P < 0.05, and there is an extremely significant difference based on P < 0.01. The correlation between HPV infection status and clinicopathologic features in exfoliated cervical cells was analyzed.

The specimen DNA quality verification was conducted using β-Actin as an internal reference for extracted specimen DNA quality to detect the nucleic acid quality by PCR amplification. The results showed that the positive control was 290 bp amplified product, and the PCR product of the specimen DNA template was consistent with that of the positive control, these results indicated that the extracted DNA met the requirements for further experiments.

According to the Bethesda grading system, the collected specimens were diagnosed by pathological cytology classification analysis according to the Bethesda grading system, they are including negative for intraepithelial lesions or malignant lesions (NILM) (Figure 1A), atypical-squamous cells of undetermined significance (ASCUS) (Figure 1B), atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASCH) (Figure 1C), Low-grade squamous intraepithelial lesion (LSIL) (Figure 1D), and High-grade squamous intraepithelial lesion (LSIL) (Figure 1E).

HPV types were analyzed by PCR amplification in 2605 cases of cervical shedding cell specimens, and 725 cases were HPV positive (positive rate 27.8%) (Figure 2). Infected HPV types in the specimens included HPV16 (82 cases), 18 (19 cases), 31 (26 cases), 33 (28 cases), 35 (15 cases), 39 (50 cases), 45 (11 cases), 51 (69 cases), 52 (144 cases), 53 (65 cases), 56 (40 cases), 58 (75 cases), 59 (19 cases), 66 (28 cases), 68 (54 cases), among which the top five highest infection rates were as follows: first, HPV52, with 5.5% infection rate; Second, the infection rate of HPV16 was about 3.1%. Third, the infection rate of HPV58 was 2.8%. Fourth, the infection rate of HPV51 was 2.6%. Fifth, the infection rate of HPV53 is 2.5%.

The collected specimens were statistically analyzed according to histological types and HPV infection. 305 HPV positive in NILM group included 37 cases HPV6 (12.1%), 6 cases HPV18 (2.0%), 5 cases HPV31 (1.6%), 5 cases HPV33 (1.0%), 5 cases HPV35 (1.0%), 30 cases HPV39 (9.8%), 25 cases HPV51 (8.2%), 69 cases HPV52 (22.6%), 23 cases HPV53 (7.5%), 18 cases HPV56 (5.9%), 39 cases HPV58 (12.8%), 4 cases HPV59 (1.3%), 7 cases HPV66 (2.3%), 32 cases HPV68 (10.5%); 172 HPV positive in ASC-US group were 26 cases HPV16 (15.1%), 2 cases HPV18 (1.2%), 5 cases HPV31 (2.9%), 7 cases HPV33 (4.1%), 3 cases HPV35 (1.7%), 18 cases HPV39 (10.5%), 3 cases HPV45 (1.7%), 13 cases HPV51 (7.6%), 37 cases HPV52 (21.5%), 15 cases HPV53 (8.7%), 7 cases HPV56 (4.1%), 21 cases HPV58 (12.2%), 15 cases HPV68 (8.7%); 105 HPV positive in ASC-H group were 5 cases HPV16 (4.8%), 3 cases HPV18 (2.9%), 8 cases HPV31 (7.6%), 9 cases HPV33 (8.6%), 3 cases HPV35 (2.9%), 6 cases HPV45 (5.7%), 12 cases HPV51 (11.4%), 7 cases HPV52 (6.7%), 21 cases HPV53 (20.0%), 5 cases HPV56 (4.8%), 3 cases HPV58 (2.9%), 5 cases HPV59 (4.8%), 11 cases HPV66 (10.5%), 7 cases HPV68 (6.7%); 91 HPV positive in LSIL group were 8 cases HPV16 (8.8%), 5 cases HPV18 (5.5%), 7 cases HPV31 (7.7%), 5 cases HPV33 (5.5%), 3 cases HPV35 (3.3%), 2 cases HPV39 (2.2%), 2 cases HPV45 (2.2%), 11 cases HPV51 (12.1%), 16 cases HPV52 (17.6%), 3 cases HPV53 (3.3%), 9 cases HPV56 (9.9%), 5 cases HPV58 (5.5%), 7 cases HPV59 (7.7%), 8 cases HPV66 (8.8%); 52 HPV positive in HSIL group were 6 cases HPV16 (11.5%), 3 cases HPV18 (5.8%), 1case HPV31 (1.9%), 2 cases HPV33 (3.8%), 1 case HPV35 (1.9%), 8 cases HPV51 (15.4%), 15 cases HPV52 (28.8%), 3 cases HPV53 (5.8%), 1 case HPV56 (1.9%), 7 cases HPV58(13.5%), 3 cases HPV59 (5.8), 2 cases HPV66 (3.8%).These HPV infection rates are irregular for different histological types ranging from NILM to HSIL. HPV positive rate in NILM group was 15.19% (105/2008), in ASC-US group was 62.55% (172/275), in the ASC-H group was 66.88% (105/157), and in the LSIL group was 81.25% (91/112), in HSIL group was 98.11% (52/53). The results of HPV infection in different pathological types shown in Table 1.

Statistical analysis showed that HPV infection of different histological types had statistical significance (P < 0.01), and the positive rate of HPV infection showed an increasing trend with the aggravation of cervical lesions.

The collected specimens were grouped according to their age as follows (Table 2): below 30 years old group, 31 - 40 years old group, 41 - 50 years old group, 51 - 60 years old group and over 61 years old group. Statistical analysis showed that there were different HPV-positive rates among different age groups, in which the highest HPV-positive rate was 33.33% (239/717) in the 41 - 50 age group. Chi-square test indicated that the difference was statistically significant (P < 0.01).

χ² = 733.415, P < 0.01.

χ² = 30.339, P < 0.01.